Top Markets
Coin of the day
Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc.

NEUP
Rank in Stocks #29434
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Share Price
$3.92
Last synced: 2026-07-31
Market Cap
$21.16M
Change (1 day)
-0.13%
Change (1 year)
-48.76%
Country
US
Trade Neuphoria Therapeutics Inc. (NEUP)

Category

Price of NEUP with the market cap of B
Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.
NEUP
$3.92
Market Capitalization of Neuphoria Therapeutics Inc.(NEUP)
Market Cap: $21.16M
As of August 2026 Neuphoria Therapeutics Inc. has a market cap of $21.16M. This makes Neuphoria Therapeutics Inc. the world's 29434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Neuphoria Therapeutics Inc. from 2021 to 2026
NEUP compared with Top 5 Most Popular stocks
Price of NEUP Asset B Mkt. of B Results
Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.
$981,872 $21.16M
$5.307T +25,079,656.31%
Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.
$842,018 $21.16M
$4.551T +21,507,393.49%
Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.
$768,679 $21.16M
$4.154T +19,634,092.51%
Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.
$663,986 $21.16M
$3.589T +16,959,951.14%
Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.
$517,498 $21.16M
$2.797T +13,218,250.04%